Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation-Reference-Cited by-同舟云学术

Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation

Published:2014-02-03 Issue:3 Volume:35 Page:410-418
ISSN:1671-4083
Container-title:Acta Pharmacologica Sinica
language:en
Short-container-title:Acta Pharmacol Sin

Author:

Yang Li,Shi Li-ping,Chen Hai-jun,Tong Xian-Kun,Wang Gui-feng,Zhang Yang-ming,Wang Wen-long,Feng Chun-lan,He Pei-lan,Zhu Feng-hua,Hao You-hua,Wang Bao-ju,Yang Dong-liang,Tang Wei,Nan Fa-jun,Zuo Jian-ping

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.nature.com/articles/aps2013175.pdf

Reference23 articles.

1. Grimm D, Thimme R, Blum HE . HBV life cycle and novel drug targets. Hepatol Int 2011; 5: 644–53.

2. Negro F . Management of chronic hepatitis B: an update. Swiss Med Wkly 2011; 141: w13264.

3. Leemans WF, Ter Borg MJ, de Man RA . Review article: success and failure of nucleoside and nucleotide analogues in chronic hepatitis B. Aliment Pharmacol Ther 2007; 26 Suppl 2: 171–82.

4. Lucifora J, Zoulim F . The life cycle of hepatitis B virus and antiviral targets. Future Virol 2011; 6: 599–614.

5. Choi IG, Yu YG . Interaction and assembly of HBV structural proteins: novel target sites of anti-HBV agents. Infect Disord Drug Targets 2007; 7: 251–6.

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal chemistry strategies in the discovery and optimization of HBV core protein allosteric modulators (2018–2022 update);Chinese Chemical Letters;2023-11

2. Anti-hepatitis B virus activities of natural products and their antiviral mechanisms;Chinese Journal of Natural Medicines;2023-11

3. Chronic Hepatitis B Infection: Current and Emerging Therapeutic Strategies;Current Topics in Medicinal Chemistry;2023-08-07

4. Design and Synthesis of (3‐Phenylisoxazol‐5‐yl)methanimine Derivatives as Hepatitis B Virus Inhibitors;Chemistry & Biodiversity;2023-02-22

5. Discovery and biological evaluation of 2-((3-phenylisoxazol-5-yl) methoxy) benzamide derivatives as potent nucleocapsid inhibitors;Journal of Molecular Structure;2023-01